Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives Average Rating of “Buy” from Analysts
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued ratings on the stock in the last […]
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued ratings on the stock in the last […]
